Clinical Trial Update: Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study [Phase 2]

View source ↗

Summary

A Phase 2 prospective trial evaluating tauroursodeoxycholic acid in combination with PD-1/PD-L1 immunotherapy for advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PD-1/PD-L1 immunotherapy (PD-1/PD-L1 inhibitors)
• Tauroursodeoxycholic acid (tauroursodeoxycholic acid)

Snippet

Sponsor: Tongji Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING